Le Lézard
Classified in: Health
Subjects: NEW PRODUCTS/SERVICES, HEALTH, LIFESTYLE, MISCELLANEOUS, MISCELLANEOUS

Fermata enters North America with a market-ready solution for LPs and growers


Toronto, ON, March 10, 2022 (GLOBE NEWSWIRE) -- Fermata, an AgTech company focused on data science and computer vision solutions, announces its expansion into the North American market. After 3 years of pilot projects and intensive research and development, Croptimus Pest and Disease, the company's AI (Artificial Intelligence) platform, is a market-ready solution that identifies pathogens through image analysis. 

Fermata was created to be a solution to challenges faced by commercial agriculture, ensuring that LPs and growers are more profitable, and making their jobs significantly easier. Croptimus promises the fastest early disease and pest identification reducing crop loss by up to 30% through detection at the earliest stages. Additionally, Fermata's solutions help growers by providing automated alerts directing them to the exact source of the problem, saving up to 50% on time normally expended on human scouting.

The expansion into North America also brings new Canadian leadership, with Alastair Monk joining Fermata as Chief Executive Officer and Ray Richards as Chief Marketing Officer. 

"As a founder of an AgTech company with 5+ years in the horticulture market and

leading digital services at Priva, I can confidently tell you there is an opportunity to make an immediate impact in this industry. Fermata has a fantastic team, solid technology, and strong global investors. I look forward to contributing to the growth in North America and worldwide as companies look for a helping hand in automating aspects of crop production," said Alastair Monk, Fermata CEO.

Ray Richards, Fermata CMO, expands, "I am excited to be joining such a great team at this crucial stage of Fermata's development. All of the pieces are in place to generate exponential growth as we enter the North American market with our machine learning solutions. We have an extremely innovative, useful product that saves growers both substantial time and money - now all we have to do is let the world know about it."

Additionally, Israel-based Company Founder Valeria Kogan is adding the role of Chief Information Officer to her current responsibilities. 

Fermata entering North America will bring new tools to growers to help them increase profitability and reduce labour. To learn more about how they aim to change everyday cultivation, visit their website here: https://fermata.tech/


-30-

About Fermata

Fermata is focused on the application of data science and computer vision solutions to

challenges faced by commercial agriculture. Engaged in extensive research since the

company's inception in 2019, Fermata has now developed an adaptive computer vision

platform designed to automatically detect pests and diseases at their earliest stages. This

early-detection platform enables growers to reliably mitigate these issues well in advance of

the point crop loss becomes inevitable, and further reduces the amount of time and money

spent on traditional scouting. For more information, please visit https://fermata.tech/



These press releases may also interest you

at 02:30
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

at 02:05
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the "Tender...

at 01:30
The global urinary catheters market  size is estimated to grow by USD 2.44 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 7.63%  during the forecast period. ...



News published on and distributed by: